#liver transplant

Risk-based testing alone has failed to identify a majority of people living with chronic HBV.

Researchers suggest cannabis use alone should not be a reason to deny transplants.

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.

New study supports U.S. guidelines for determining which people with liver cancer are eligible for a transplant.

Heavy alcohol use among people with hepatitis B or C increased the risk of liver cancer.

A steep rise in drug overdose deaths during the pandemic led to greater availability of donor organs.

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.

Immunocompromised people ages 12 and older are also eligible for an additional shot.

Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.

Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.

Organ transplant recipients take immunosuppressive drugs that impair immune response to pathogens and vaccines.

Experts recommend no more than two drinks for men or one drink for women per day.

The drug, which blocks entry of HBV into liver cells, also prevents HDV replication.